Index RUT
P/E -
EPS (ttm) -4.59
Insider Own 34.50%
Shs Outstand 134.78M
Perf Week 3.46%
Market Cap 1.12B
Forward P/E -
EPS next Y -3.97
Insider Trans -0.36%
Shs Float 88.97M
Perf Month -18.56%
Income -615.06M
PEG -
EPS next Q -1.05
Inst Own 53.10%
Short Float 5.79%
Perf Quarter -13.87%
Sales 86.18M
P/S 12.96
EPS this Y 10.73%
Inst Trans -5.33%
Short Ratio 4.91
Perf Half Y -1.02%
Book/sh 11.80
P/B 0.70
EPS next Y 3.16%
ROA -24.54%
Short Interest 5.15M
Perf Year -66.36%
Cash/sh 11.31
P/C 0.73
EPS next 5Y 7.00%
ROE -33.53%
52W Range 7.61 - 27.48
Perf YTD -18.24%
Dividend Est. -
P/FCF -
EPS past 5Y -34.12%
ROI -36.14%
52W High -70.07%
Beta 0.49
Dividend TTM -
Quick Ratio 9.05
Sales past 5Y 421.39%
Gross Margin 67.01%
52W Low 8.08%
ATR (14) 0.42
Dividend Ex-Date Aug 25, 2010
Current Ratio 9.05
EPS Y/Y TTM -217.39%
Oper. Margin -742.41%
RSI (14) 37.80
Volatility 4.64% 4.20%
Employees 587
Debt/Eq 0.08
Sales Y/Y TTM -94.67%
Profit Margin -713.69%
Recom 1.78
Target Price 29.50
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q -12.92%
Payout -
Rel Volume 0.68
Prev Close 7.63
Sales Surprise 50.21%
EPS Surprise 14.67%
Sales Q/Q -66.03%
Earnings May 02 AMC
Avg Volume 1.05M
Price 8.23
SMA20 -7.46%
SMA50 -17.54%
SMA200 -22.47%
Trades
Volume 621,397
Change 7.80%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Downgrade
JP Morgan
Overweight → Neutral
$23 → $9
Sep-08-23 Downgrade
BofA Securities
Buy → Neutral
$23 → $14
Mar-06-23 Upgrade
JP Morgan
Neutral → Overweight
$35 → $34
Feb-21-23 Upgrade
Goldman
Neutral → Buy
$41 → $53
Jan-27-23 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$18 → $30
Sep-14-22 Initiated
SVB Leerink
Outperform
$40
Sep-09-22 Initiated
Morgan Stanley
Underweight
$15
Mar-03-22 Upgrade
Robert W. Baird
Underperform → Neutral
$36 → $28
Dec-21-21 Downgrade
Robert W. Baird
Neutral → Underperform
$36
Oct-25-21 Upgrade
JP Morgan
Underweight → Neutral
$29 → $37
Sep-22-21 Downgrade
Goldman
Buy → Neutral
$64 → $62
Jun-04-21 Resumed
Robert W. Baird
Neutral
$45
Jan-27-21 Downgrade
JP Morgan
Neutral → Underweight
$30
Jan-20-21 Reiterated
H.C. Wainwright
Buy
$100 → $125
Oct-05-20 Initiated
BofA Securities
Buy
$55
Sep-14-20 Upgrade
Goldman
Neutral → Buy
$48 → $54
Sep-11-20 Upgrade
JP Morgan
Underweight → Neutral
$29
Aug-20-20 Initiated
Needham
Buy
$62
Mar-19-20 Downgrade
JP Morgan
Neutral → Underweight
$26
Mar-13-20 Downgrade
Goldman
Buy → Neutral
Show Previous Ratings
Apr-24-24 12:00PM
Apr-18-24 08:00AM
Apr-11-24 04:30PM
Apr-04-24 07:01PM
Mar-22-24 07:00AM
02:58PM
Loading…
Mar-19-24 02:58PM
Mar-13-24 11:07AM
Mar-05-24 08:05AM
Feb-23-24 01:54PM
(Thomson Reuters StreetEvents) +11.94%
10:34AM
09:55AM
08:05AM
Feb-22-24 05:50PM
04:05PM
Feb-20-24 04:30PM
03:45PM
Loading…
Feb-14-24 03:45PM
Feb-01-24 04:05PM
Jan-15-24 11:32AM
Dec-17-23 07:00AM
07:00AM
Dec-13-23 04:05PM
Dec-06-23 04:05PM
Nov-30-23 06:10AM
Nov-13-23 08:00AM
Nov-10-23 08:00AM
Nov-08-23 08:05AM
Nov-04-23 11:42AM
Nov-03-23 09:02AM
(Thomson Reuters StreetEvents) +6.96%
Nov-02-23 07:00PM
04:05PM
08:00AM
Loading…
Oct-30-23 08:00AM
Oct-23-23 02:50AM
Oct-12-23 04:05PM
Oct-11-23 08:00AM
Oct-05-23 04:30PM
Oct-03-23 07:59AM
Sep-20-23 08:00AM
Sep-19-23 05:07AM
Sep-08-23 09:34AM
Aug-29-23 04:30PM
Aug-12-23 11:05AM
Aug-11-23 10:15AM
Aug-07-23 06:03AM
Aug-04-23 01:40PM
Aug-03-23 06:05PM
04:05PM
Jul-26-23 04:05PM
Jul-21-23 10:11AM
Jul-20-23 04:50PM
(American City Business Journals) -44.90%
11:31AM
08:00AM
Jun-29-23 09:00AM
Jun-25-23 08:00AM
Jun-24-23 05:30AM
Jun-21-23 08:00PM
Jun-07-23 02:13AM
Jun-05-23 04:05PM
May-17-23 04:05PM
May-16-23 09:25AM
May-15-23 08:35AM
08:00AM
May-11-23 08:30AM
May-10-23 02:07PM
May-04-23 07:45PM
05:48PM
04:05PM
May-03-23 04:05PM
May-02-23 09:00AM
Apr-28-23 10:00AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 04:05PM
Apr-05-23 01:40PM
Mar-29-23 08:40AM
Mar-21-23 02:33PM
Mar-08-23 04:05PM
Mar-05-23 07:30AM
Mar-03-23 06:57PM
Feb-28-23 04:05PM
Feb-26-23 07:13AM
Feb-23-23 05:35PM
04:05PM
Feb-22-23 08:30AM
Feb-20-23 10:00AM
Feb-16-23 04:05PM
10:01AM
08:30AM
Feb-14-23 04:33PM
08:19AM
Feb-13-23 04:45PM
Feb-02-23 02:19PM
Jan-31-23 10:06AM
Jan-25-23 06:05PM
(American City Business Journals)
08:29AM
Jan-24-23 12:00PM
Jan-22-23 07:15AM
Jan-21-23 04:51PM
07:36AM
Jan-20-23 09:40AM
Jan-03-23 04:05PM
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
De Backer Marianne Chief Executive Officer Apr 03 '24 Sale 9.46 72,995 690,365 678,457 Apr 04 04:14 PM HANLY ANN M. EVP & Chief Technology Officer Apr 01 '24 Sale 10.05 2,711 27,251 132,069 Apr 02 08:58 PM Lee Sung EVP & Chief Financial Officer Mar 27 '24 Sale 9.89 6,008 59,404 100,492 Mar 28 12:18 PM SCANGOS GEORGE A Director Feb 26 '24 Sale 11.65 17,722 206,522 112,989 Feb 26 07:30 PM Pang Phillip EVP & Chief Medical Officer Feb 22 '24 Sale 10.05 14,568 146,344 250,111 Feb 26 07:31 PM HANLY ANN M. EVP & Chief Technology Officer Feb 22 '24 Sale 10.05 12,296 123,521 134,780 Feb 26 07:34 PM SCANGOS GEORGE A Director Feb 22 '24 Sale 10.05 10,028 100,737 130,711 Feb 26 07:30 PM SCANGOS GEORGE A Director Feb 20 '24 Sale 10.22 16,872 172,385 140,739 Feb 20 09:02 PM SCANGOS GEORGE A Director Feb 16 '24 Sale 10.24 10,878 111,386 157,611 Feb 20 09:02 PM Pang Phillip EVP & Chief Medical Officer Feb 16 '24 Sale 10.24 3,321 34,006 264,679 Feb 16 06:56 PM Pang Phillip EVP & Chief Medical Officer Jan 02 '24 Option Exercise 1.38 80,000 110,299 268,000 Jan 03 02:47 PM SATO VICKI L Director Jun 30 '23 Sale 24.66 18,000 443,916 1,315,351 Jul 03 04:15 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 30 '23 Sale 25.11 700 17,577 16,684,041 Jul 05 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 29 '23 Sale 25.18 89,942 2,264,731 16,684,741 Jun 30 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 28 '23 Sale 25.10 7,010 175,922 16,774,683 Jun 30 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 20 '23 Sale 25.18 9,902 249,302 16,781,693 Jun 22 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 16 '23 Sale 25.43 128,144 3,258,980 16,791,595 Jun 20 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 15 '23 Sale 25.85 55,182 1,426,680 16,919,739 Jun 20 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 14 '23 Sale 26.13 57,248 1,495,618 16,974,921 Jun 15 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 13 '23 Sale 27.09 106,854 2,894,180 17,032,169 Jun 15 09:00 PM Pang Phillip Chief Medical Officer Jun 07 '23 Option Exercise 1.53 5,000 7,650 193,000 Jun 08 04:30 PM Pang Phillip Chief Medical Officer Jun 07 '23 Sale 25.95 5,000 129,727 188,000 Jun 08 04:30 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 05 '23 Sale 27.32 5,197 141,998 17,139,023 Jun 06 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner Jun 02 '23 Sale 27.32 34,365 938,732 17,144,220 Jun 06 09:00 PM Ramasastry Saira Director Jun 01 '23 Sale 25.67 3,500 89,845 10,619 Jun 02 12:19 PM Rice Steven J. Chief Administrative Officer Jun 01 '23 Sale 25.67 2,500 64,175 106,840 Jun 02 12:20 PM SVF Endurance (Cayman) Ltd 10% Owner May 24 '23 Sale 26.15 104,384 2,729,599 17,178,585 May 25 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 23 '23 Sale 26.66 170,067 4,533,230 17,282,969 May 25 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 22 '23 Sale 25.72 91,896 2,363,905 17,453,036 May 23 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 19 '23 Sale 25.38 91,651 2,326,231 17,544,932 May 23 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 05 '23 Sale 25.10 136 3,414 17,636,583 May 09 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 04 '23 Sale 25.55 114,332 2,921,160 17,636,719 May 05 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 03 '23 Sale 25.51 83,674 2,134,691 17,751,051 May 05 09:00 PM SVF Endurance (Cayman) Ltd 10% Owner May 01 '23 Sale 25.30 3,075 77,812 17,834,725 May 03 09:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite